In this webinar, learn what targets are suitable, what are the trends in linkers and the drugs to be attached to the antibodies, how are companies dealing with the complexities of internalization and high cost of goods, what kind of data will drive an ADC licensing deal, how do the ADCs fit in the world of immuno-oncology and what is the future for ADCs.

This webinar presents an overview of the current CNS drug market landscape and how it compares to other therapeutic areas.

This webinar discusses lessons we can learn from the use of precision medicine in oncology, how has a recent clinical precision medicine application shown potential in the treatment of Alzheimer’s, what questions should you ask before you add a new biomarker to your clinical trial, the pros and cons of using biomarkers as surrogate endpoints.

Hear real stories from people who have hit the trenches from the entrepreneurial business CEO perspective and have run the gauntlet to an exit.

This webinar dives into how representations and warranties insurance can play an integral part of negotiating transactions, winning bids, and finding a means of closing deals in today’s challenging M&A environment.

This webinar focuses on best practices in due diligence with the goal of forming productive biopharma partnerships.

This webinar will teach you what drives the seller’s value expectations, how buyers approach valuations, the biggest risks buyers should seek to minimize, and the creative structures to bridge the valuation gap.

This webinar explores best practices in corporate IP monetization strategies and discuss the successful ways that the Tech+IP Advisory practice has applied an M&A-like process to patent monetization.

In this webinar, learn what is artificial intelligence and how is it being applied to drug discovery, and much more.

In this webinar, you’ll learn best practices on how to setup and use ShareVault more effectively and efficiently.

This webinar explores today’s oncology landscape, perspective on trends, pipeline by indication, dealmaking, and the top ten oncology companies and the drugs they’re developing.

This webinar presents an introduction to the key concepts and most common methodologies used to evaluate life sciences assets.